Matrixx Initiatives, Inc. Reports Fiscal 3rd Quarter Net Sales of $30.8 Million and Net Loss of ($0.07)...(uarter endedDecember 31 2007 was approxi...),Health

Date:1/30/2008

uarter ended December 31, 2007 was approximately $360,000 below the level incurred in the same period of 2006, primarily due to the favorable closure of the FTC inquiry that occurred last year. In addition, for the quarter ended December 31, 2007 we realized a decrease in marketing expense of approximately $2.7 million. Selling expense was reduced approximately $100,000, which was related to the lower level of sales realized during the quarter. Research and development expense increased approximately $330,000 as we continue to develop new product initiatives."

There will be a teleconference Thursday, January 31, 2008 at 11:00 a.m. EDT to discuss the fiscal third quarter financial results. To access the teleconference, please call (877) 863-5191 (domestic) or (706) 643-6826 (international), access code 32145727. To listen to the teleconference via the Internet, go to http://www.matrixxinc.com and click on the fiscal 2008 third quarter financial results teleconference icon. A replay of the call will be available at (800) 642-1687 (domestic) or (706) 645-9291 (international), access number 32145727, for 3 days following the call, and the web cast will be archived on the Company's website, http://www.matrixxinc.com, for 30 days.

Third Quarter Fiscal 2008 Consolidated Financial Results (Unaudited)

Three Three Nine Nine

months months months months

ended Dec. 31, ended Dec. 31, ended Dec 31, ended Dec 31,

($000s) 2007 2006 2007 2006

Net Sales $30,802 $36,227 $67,951 $78,555

Cost of Sales 11,060 13,021 23,472 26,580

Gross Profit 19,742 23,206 44,479 51,975

Operat
'/>"/>

SOURCE Matrixx Initiatives, Inc. Copyright©2008 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3 4 5 6 7 8
Related medicine news :

1. Matrixx Initiatives, Inc. Sets Time for Discussion of Third Quarter Fiscal 2008 Financial Results
2. Matrixx Initiatives, Inc. Updates 2007/2008 Cold Season Trends and Fiscal 2008 Sales and Earnings Outlook
3. Matrixx Initiatives, Inc. to Present at the William Blair & Company Small-Cap Growth Stock Conference
4. Matrixx Initiatives, Inc. to Present at the Roth Capital Partners 2007 New York Conference
5. Accuray Reports Continued Growth in Second Quarter of Fiscal 2008
6. Cardinal Health Reports Second Quarter Results, Revises EPS Outlook
7. Encision Reports Third Fiscal Quarter Results
8. Zimmer Reports Fourth Quarter and 2007 Financial Results
9. Amylin Pharmaceuticals Reports 2007 Financial Results
10. Cystic Fibrosis Foundation reports upward trend for key health outcomes
11. NBTY Reports First Quarter Results